TUESDAY, Oct. 15, 2024 (HealthDay News) — Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list. What prompted the FDA to reconsider its decision? On Oct.Continue Reading

THURSDAY, Sept. 26, 2024 (HealthDay News) — There’s good news for folks who struggle to fit regular exercise into their busy workweek. “Weekend warrior” workouts are just as beneficial as daily exercise to a person’s overall health, a new study says. People who get all their weekly recommended exercise inContinue Reading

WEDNESDAY, Sept. 25, 2024 (HealthDay News) — In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose. People with type 2 diabetes prescribed semaglutide (Ozempic, Wegovy) had a significantly lower riskContinue Reading

WEDNESDAY, Sept. 25, 2024 (HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster drugs Ozempic and Wegovy. While testifying before the Senate Committee on Health, Education, Labor and Pensions,Continue Reading